JPRN-UMIN000007345已完成2 期
A phase 2 study of mid-term compliance and effectiveness of dasatinib therapy in patients with chronic myeloid leukemia. - DARIA 01 Trial
Epidemiological and Clinical Research Information Network(ECRIN)0 个研究点目标入组 30 人开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Pregnant and/or lactating woman 2. Other active neoplasms 3. History of sever bleeding tendency 4. Psychological disorders 5. Recent history of ischemic heart disease
研究者
相似试验
进行中（未招募）
不适用
A clinical trial investigating OSI-906 in patients with cancer of thesurface of the ovary and other solid tumorsRecurrent Epithelial Ovarian Cancer and Other Solid TumorsMedDRA version: 14.1Level: LLTClassification code 10049280Term: Solid tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010319-34-ITASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.199
进行中（未招募）
1 期
A clinical trial investigating OSI-906 in patients with cancer of the surface of the ovary and other solid tumorsRecurrent Epithelial Ovarian Cancer and Other Solid TumorsMedDRA version: 14.1 Level: LLT Classification code 10049280 Term: Solid tumour System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10066697 Term: Ovarian cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010319-34-GBAstellas Pharma Global Development, Inc.210
进行中（未招募）
不适用
A clinical trial investigating OSI-906 in patients with cancer of the surface of the ovary and other solid tumorsEUCTR2009-010319-34-PLAstellas Pharma Global Development, Inc.199
进行中（未招募）
不适用
A clinical trial investigating OSI-906 in patients with cancer of the surface of the ovary and other solid tumorsRecurrent Epithelial Ovarian Cancer and Other Solid TumorsMedDRA version: 14.1Level: LLTClassification code 10049280Term: Solid tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010319-34-CZAstellas Pharma Global Development, Inc.199
已完成
不适用
Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and AdherenceMedication AdherenceNCT02344251Medical University of South Carolina40